100 results
Page 2 of 5
8-K
EX-99.1
z3j7ds1bxnof63a
24 Feb 22
Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2021 Financial Results
4:27pm
8-K
EX-99.2
1l8bx3unan luzyxs40
24 Feb 22
Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2021 Financial Results
4:27pm
8-K
EX-99.1
2hsypz
4 Nov 21
Vir Biotechnology Provides Corporate Update and Reports Third Quarter 2021 Financial Results
4:07pm
8-K
EX-99.1
ajszki4dzevhsca0
5 Aug 21
Vir Biotechnology Provides Corporate Update and Reports Second Quarter 2021 Financial Results
4:14pm
8-K
xh2rer0f1itz 4douq3
28 Jun 21
Other Events
6:07am
8-K
EX-99.1
btdi8z
27 May 21
GSK and Vir Biotechnology Announce Sotrovimab (VIR-7831) Receives
4:55pm
8-K
EX-99.2
3mys5s2 d2vxoot
27 May 21
GSK and Vir Biotechnology Announce Sotrovimab (VIR-7831) Receives
4:55pm
8-K
8b8ws56o
27 May 21
GSK and Vir Biotechnology Announce Sotrovimab (VIR-7831) Receives
4:55pm
8-K
EX-99.1
c596ee3g9jueq31y
21 May 21
CORRECTION — EMA Issues Positive Scientific Opinion on GSK and Vir Biotechnology’s
3:38pm
8-K
EX-99.1
6gvexw19sr8gzi bm
6 May 21
Vir Biotechnology Provides Corporate Update and Reports First Quarter 2021 Financial Results
4:24pm
8-K
EX-99.1
bcsbgi
13 Apr 21
Other Events
4:06pm
8-K
EX-99.1
oyr6jpncysyo3
25 Feb 21
Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2020 Financial Results
4:15pm